Completed
Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis
What is being collected
Data Collection
+ other Data
Collected from today forward - ProspectiveOther
Who is being recruted
Bipolar and Related Disorders+4
+ Mental Disorders
+ Mood Disorders
From 18 to 45 Years
+4 Eligibility Criteria
How is the trial designed
Case-Control
Comparing exposures between individuals with and without disease in order to identify potential risk factors.Observational
Study Start: October 2012
Summary
Principal SponsorMclean Hospital
Last updated: September 27, 2022
Sourced from a government-validated database.Claim as a partner
Study start date: October 17, 2012
Actual date on which the first participant was enrolled.The purpose of this study is to investigate the structural, functional and chemical brain abnormalities in patients with first episode psychosis and assess the evolution of these abnormalities during the course of the disease. The study design is case-control, there are no interventions.
Principal SponsorMclean Hospital
Last updated: September 27, 2022
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
187 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-Control
These studies compare people who have a disease (cases) with those who don't (controls). The goal is to look back at previous exposures or risk factors to identify what might have contributed to the disease.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.From 18 to 45 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Bipolar and Related DisordersMental DisordersMood DisordersSchizophrenia Spectrum and Other Psychotic DisordersBipolar DisorderPsychotic DisordersSchizophrenia
Criteria
2 inclusion criteria required to participate
Clinical diagnosis of first episode of a psychotic disorder
Healthy controls with no psychiatric disorder history
2 exclusion criteria prevent from participating
Ages < 18 or > 45
Significant neurological or medical illness history
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
CompletedOne Study Center